Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urged Post author: Post published:May 3, 2024 Post category:uncategorized Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs). You Might Also Like Large-scale study reveals joint functional and structural patterns of brain aging December 18, 2025 Diabetes drugs may reduce risk of opioid overdose and alcohol intoxication October 22, 2024 Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes October 29, 2023
Stopping metformin early linked to higher dementia risk in older adults with type 2 diabetes October 29, 2023